Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$322M |
| 2 |
UnitedHealth
UNH
|
+$233M |
| 3 |
Microsoft
MSFT
|
+$198M |
| 4 |
International Flavors & Fragrances
IFF
|
+$171M |
| 5 |
Principal Financial Group
PFG
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$714M |
| 2 |
IBM
IBM
|
+$395M |
| 3 |
Cisco
CSCO
|
+$303M |
| 4 |
Procter & Gamble
PG
|
+$290M |
| 5 |
Macy's
M
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.98% |
| 2 | Financials | 14.9% |
| 3 | Healthcare | 12.91% |
| 4 | Industrials | 10.1% |
| 5 | Consumer Discretionary | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXAS
2176
DELISTED
Exact Sciences
EXAS
| $6.53M | ﹤0.01% |
488,411
+21,684
| +5% | +$350K |
|
2177
Enanta Pharmaceuticals
ENTA
$383M
| $6.5M | ﹤0.01% |
194,056
+2,899
| +2% | +$83.1K |
|
2178
IDT Corp
IDT
$1.66B
| $6.49M | ﹤0.01% |
413,878
-66,909
| -14% | -$1.08M |
|
|
AVTA
2179
DELISTED
Avantax, Inc. Common Stock
AVTA
| $6.47M | ﹤0.01% |
438,654
+22,623
| +5% | +$305K |
|
2180
Motorcar Parts of America
MPAA
$236M
| $6.46M | ﹤0.01% |
239,891
+12,961
| +6% | +$342K |
|
2181
Titan International
TWI
$445M
| $6.42M | ﹤0.01% |
572,594
+90,271
| +19% | +$988K |
|
2182
Theravance Biopharma
TBPH
$881M
| $6.4M | ﹤0.01% |
200,835
-21,009
| -9% | -$652K |
|
2183
Pacira BioSciences
PCRX
$917M
| $6.4M | ﹤0.01% |
198,069
+8,308
| +4% | +$277K |
|
|
CLDT
2184
Chatham Lodging
CLDT
$605M
| $6.38M | ﹤0.01% |
310,555
+17,806
| +6% | +$342K |
|
2185
Artivion
AORT
$1.42B
| $6.38M | ﹤0.01% |
333,182
+3,909
| +1% | +$71.2K |
|
2186
TransUnion
TRU
$15.4B
| $6.36M | ﹤0.01% |
205,618
+7,995
| +4% | +$251K |
|
2187
Crocs
CROX
$6.32B
| $6.34M | ﹤0.01% |
923,709
+13,205
| +1% | +$102K |
|
2188
Univest Financial
UVSP
$1.19B
| $6.34M | ﹤0.01% |
205,047
-4,094
| -2% | -$109K |
|
|
BKMU
2189
DELISTED
Bank Mutual Corp
BKMU
| $6.33M | ﹤0.01% |
670,249
+54,479
| +9% | +$462K |
|
|
HIFR
2190
DELISTED
InfraREIT, Inc.
HIFR
| $6.33M | ﹤0.01% |
353,154
+131,622
| +59% | +$2.25M |
|
|
SASR
2191
DELISTED
Sandy Spring Bancorp Inc
SASR
| $6.32M | ﹤0.01% |
158,095
+14,831
| +10% | +$513K |
|
2192
Varonis Systems
VRNS
$5.17B
| $6.32M | ﹤0.01% |
707,049
+546,582
| +341% | +$5.2M |
|
2193
Invesco Senior Loan ETF
BKLN
$6.76B
| $6.32M | ﹤0.01% |
270,345
+20,637
| +8% | +$479K |
|
2194
MarineMax
HZO
$1.15B
| $6.31M | ﹤0.01% |
326,309
+3,961
| +1% | +$76.5K |
|
|
ZNGA
2195
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $6.31M | ﹤0.01% |
2,455,344
+161,078
| +7% | +$455K |
|
|
UBNK
2196
DELISTED
United Financial Bancorp, Inc.
UBNK
| $6.3M | ﹤0.01% |
346,863
+34,591
| +11% | +$554K |
|
2197
Biglari Holdings Class B
BH
$1.21B
| $6.29M | ﹤0.01% |
19,955
-348
| -2% | -$105K |
|
2198
Myers Industries
MYE
$1.24B
| $6.27M | ﹤0.01% |
438,125
+45,207
| +12% | +$614K |
|
|
ERUS
2199
DELISTED
iShares MSCI Russia ETF
ERUS
| $6.23M | ﹤0.01% |
185,950
+1
| +0% | +$30 |
|
2200
Vermilion Energy
VET
$1.73B
| $6.22M | ﹤0.01% |
147,595
-2,822
| -2% | -$115K |
|
Similar funds
Bank of New York Mellon's Q4 2016 Portfolio in Review
As of Q4 2016, Bank of New York Mellon held 4,430 positions worth $347B, up 3.3% from $336B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bank of New York Mellon's Q4 2016 filing shows 161 new, 2,590 increased, 1,402 reduced and 170 closed positions. Its largest new stake was Lamb Weston: 2,449,932 shares worth $92.7M. The largest sale was Merck, an estimated $714M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q4 2016 buy was Lamb Weston: 2,449,932 shares worth $92.7M.
- Bank of New York Mellon added most to CME Group in Q4 2016, an estimated $322M increase.
- Bank of New York Mellon's biggest Q4 2016 reduction was Merck, cutting an estimated $714M.
- Bank of New York Mellon fully exited LinkedIn Corporation in Q4 2016, selling an estimated $82.8M.
- Bank of New York Mellon's ten largest holdings make up 13% of its $347B portfolio in Q4 2016.
- Bank of New York Mellon opened 161 new positions and closed 170 in Q4 2016.
- Bank of New York Mellon's portfolio value rose 3.3% quarter-over-quarter to $347B.
Based on Bank of New York Mellon's 13F filing for Q4 2016, filed 13 Feb 2017.